Grifols S.A.

15.22-0.0700-0.46%Vol 236.31K1Y Perf -5.94%
Sep 23rd, 2021 14:12 DELAYED
BID15.22 ASK15.23
Open15.28 Previous Close15.29
Pre-Market15.48 After-Market-
 0.19 1.24%  - -
Target Price
18.45 
Analyst Rating
Moderate Buy 2.20
Potential %
21.14 
Finscreener Ranking
★★★+     52.20
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★★     52.15
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★★     51.56
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
★+     36.46
Price Range Ratio 52W %
18.67 
Earnings Rating
Neutral
Market Cap10.33B 
Earnings Date
4th Nov 2021
Alpha-0.01 Standard Deviation0.07
Beta0.57 

Today's Price Range

15.2215.52

52W Range

14.0120.49

5 Year PE Ratio Range

13.1028.70

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Buy
Performance
1 Week
5.81%
1 Month
2.69%
3 Months
-11.82%
6 Months
-8.88%
1 Year
-5.94%
3 Years
-27.64%
5 Years
-5.21%
10 Years
179.84%

TickerPriceChg.Chg.%
GRFS15.22-0.0700-0.46
AAPL146.820.97000.67
GOOG2 840.6821.91000.78
MSFT299.711.13000.38
XOM57.061.85003.35
WFC48.040.96002.04
JNJ165.481.55000.95
FB346.273.06000.89
GE103.575.03005.10
JPM161.475.56003.57
Financial StrengthValueIndustryS&P 500US Markets
0.50
1.70
0.57
1.48
5.40
Leverage Ratio 3.00
ProfitabilityValueIndustryS&P 500US Markets
44.80
22.00
28.30
16.50
14.42
RevenueValueIndustryS&P 500US Markets
6.46B
9.40
6.48
6.06
DividendsValueIndustryS&P 500US Markets
4.67
0.72
-8.19
-0.79
Payout ratio19.00
Earnings HistoryEstimateReportedSurprise %
Q02 20210.270.3529.63
Q01 2021-0.21-
Q04 20200.380.29-23.68
Q03 20200.340.365.88
Q02 20200.370.35-5.41
Q01 20200.240.254.17
Q04 20190.310.310.00
Q03 20190.310.28-9.68
Earnings Per EndEstimateRevision %Trend
6/2021 QR0.380.00-
9/2021 QR0.30-76.56Negative
12/2021 FY1.26-1.56Negative
12/2022 FY1.53-1.92Negative
Next Report Date4th Nov 2021
Estimated EPS Next Report0.30
Estimates Count1
EPS Growth Next 5 Years %12.10
Volume Overview
Volume236.31K
Shares Outstanding678.54M
Shares Float687.56M
Trades Count2.35K
Dollar Volume24.57M
Avg. Volume769.63K
Avg. Weekly Volume655.63K
Avg. Monthly Volume590.93K
Avg. Quarterly Volume709.93K

Grifols S.A. (NASDAQ: GRFS) stock closed at 15.29 per share at the end of the most recent trading day (a -1.99% change compared to the prior day closing price) with a volume of 248.24K shares and market capitalization of 10.33B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Drug Manufacturers industry, Healthcare sector and employs 23655 people. Grifols S.A. CEO is Raimon Grifols Roura / Víctor Grifols Deu.

The one-year performance of Grifols S.A. stock is -5.94%, while year-to-date (YTD) performance is -17.08%. GRFS stock has a five-year performance of -5.21%. Its 52-week range is between 14.01 and 20.49, which gives GRFS stock a 52-week price range ratio of 18.67%

Grifols S.A. currently has a PE ratio of 12.90, a price-to-book (PB) ratio of 1.73, a price-to-sale (PS) ratio of 1.64, a price to cashflow ratio of 9.90, a PEG ratio of 2.32, a ROA of 4.19%, a ROC of 6.59% and a ROE of 12.67%. The company’s profit margin is 14.42%, its EBITDA margin is 28.30%, and its revenue ttm is $6.46 Billion , which makes it $9.40 revenue per share.

Of the last four earnings reports from Grifols S.A., there were 2 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $0.30 for the next earnings report. Grifols S.A.’s next earnings report date is 04th Nov 2021.

The consensus rating of Wall Street analysts for Grifols S.A. is Moderate Buy (2.2), with a target price of $18.45, which is +21.14% compared to the current price. The earnings rating for Grifols S.A. stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Grifols S.A. has a dividend yield of 4.67% with a dividend per share of $0.72 and a payout ratio of 19.00%.

Grifols S.A. has a Buy technical analysis rating based on Technical Indicators (ADX : 12.19, ATR14 : 0.44, CCI20 : 149.51, Chaikin Money Flow : -0.08, MACD : 0.09, Money Flow Index : 69.97, ROC : 3.87, RSI : 58.43, STOCH (14,3) : 75.29, STOCH RSI : 0.72, UO : 52.05, Williams %R : -24.71), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Grifols S.A. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (60.00 %)
3 (60.00 %)
4 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (20.00 %)
2 (40.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
1 (20.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
2.20
Moderate Buy
1.80
Strong Buy
1.00

Grifols S.A.

As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and the firm's bioscience business contributed 78% of sales in 2019. Grifols also has smaller segments including diagnostics, hospital supplies, and biosupplies. Diagnostics is now roughly 14% of revenue following the Novartis and Hologic deals.

CEO: Raimon Grifols Roura / Víctor Grifols Deu

Telephone: +34 935710500

Address: Avinguda de la Generalitat, 152-158, Barcelona 08174, , ES

Number of employees: 23 655

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

67%33%

Bearish Bullish

48%52%

Bearish Bullish

61%39%

News

Stocktwits